Egyptian Journal of Medical Human Genetics

Table 6 Serum level of sHLA-G antigens in inflammatory bowel disease (ulcerative colitis and Crohn’s disease) patients and controls distributed according to HLA-G 14-bp insertion/deletion genotypes

From: Susceptibility role of soluble HLA-G and HLA-G 14-bp insertion/deletion polymorphism in inflammatory bowel disease

Group^a	sHLA-G (mean ± SD); ng/ml			p
Group^a	Ins/Ins	Ins/Del	Del/Del	p
Control (N = 19:5:6)	122.2 ± 16.6	135.5 ± 15.2	126.0 ± 14.5	0.314
UC (N = 19:6:5)	183.7 ± 17.9	180.0 ± 46.8	179.8 ± 22.4	0.958
CD (N = 21:7:2)	172.5 ± 34.9	165.0 ± 26.2	169.9 ± 27.0	0.894

UC ulcerative colitis, CD Crohn’s disease, SD standard deviation, Ins insertion, Del deletion, p one-way ANOVA (analysis of variance) probability
^a Numbers of Ins/Ins, Ins/Del, and Del/Del are given in parentheses, respectively

Back to article page